• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

探讨成人小脑高级别胶质瘤的独特临床特征并构建生存概率列线图模型。

Investigating distinct clinical features and constructing a nomogram model for survival probability in adults with cerebellar high-grade gliomas.

机构信息

Department of Neurosurgery and Neurosurgery Research Laboratory, West China Hospital, Sichuan University, Chengdu, China.

Clinical Medicine School, Traditional Chinese Medicine of Jiangxi University, Jiangxi, China.

出版信息

BMC Cancer. 2024 Jul 13;24(1):836. doi: 10.1186/s12885-024-12580-4.

DOI:10.1186/s12885-024-12580-4
PMID:39003457
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11245792/
Abstract

BACKGROUND

The clinical features of cerebellar high-grade gliomas (cHGGs) in adults have not been thoroughly explored. This large-scale, population-based study aimed to comprehensively outline these traits and construct a predictive model.

METHODS

Patient records diagnosed with gliomas were collected from various cohorts and analyzed to compare the features of cHGGs and supratentorial HGGs (sHGGs). Cox regression analyses were employed to identify prognostic factors for overall survival and to develop a nomogram for predicting survival probabilities in patients with cHGGs. Multiple machine learning methods were applied to evaluate the efficacy of the predictive model.

RESULTS

There were significant differences in prognosis, with SEER-cHGGs showing a median survival of 7.5 months and sHGGs 14.9 months (p < 0.001). Multivariate Cox regression analyses revealed that race, WHO grade, surgical procedures, radiotherapy, and chemotherapy were independent prognostic factors for cHGGs. Based on these factors, a nomogram was developed to predict 1-, 3-, and 5-year survival probabilities, with AUC of 0.860, 0.837, and 0.810, respectively. The model's accuracy was validated by machine learning approaches, demonstrating consistent predictive effectiveness.

CONCLUSIONS

Adult cHGGs are distinguished by distinctive clinical features different from those of sHGGs and are associated with an inferior prognosis. Based on these risk factors affecting cHGGs prognosis, the nomogram prediction model serves as a crucial tool for clinical decision-making in patient care.

摘要

背景

成人小脑高级别胶质瘤(cHGG)的临床特征尚未得到充分探索。本大规模、基于人群的研究旨在全面概述这些特征并构建预测模型。

方法

从各种队列中收集诊断为胶质瘤的患者记录,并进行分析以比较 cHGG 和幕上高级别胶质瘤(sHGG)的特征。采用 Cox 回归分析确定总生存期的预后因素,并为 cHGG 患者的生存概率开发预测列线图。应用多种机器学习方法评估预测模型的疗效。

结果

预后存在显著差异,SEER-cHGG 的中位生存期为 7.5 个月,sHGG 为 14.9 个月(p<0.001)。多变量 Cox 回归分析显示,种族、WHO 分级、手术方式、放疗和化疗是 cHGG 的独立预后因素。基于这些因素,开发了一个列线图来预测 1、3 和 5 年的生存率,AUC 分别为 0.860、0.837 和 0.810。通过机器学习方法验证了该模型的准确性,表明具有一致的预测效果。

结论

成人 cHGG 具有与 sHGG 不同的独特临床特征,预后较差。基于这些影响 cHGG 预后的风险因素,该列线图预测模型是患者治疗中临床决策的重要工具。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/72bb/11245792/b2b3262920b8/12885_2024_12580_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/72bb/11245792/b500540a2e40/12885_2024_12580_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/72bb/11245792/6ac322ab60cc/12885_2024_12580_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/72bb/11245792/1a4da276f06d/12885_2024_12580_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/72bb/11245792/b2b3262920b8/12885_2024_12580_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/72bb/11245792/b500540a2e40/12885_2024_12580_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/72bb/11245792/6ac322ab60cc/12885_2024_12580_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/72bb/11245792/1a4da276f06d/12885_2024_12580_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/72bb/11245792/b2b3262920b8/12885_2024_12580_Fig4_HTML.jpg

相似文献

1
Investigating distinct clinical features and constructing a nomogram model for survival probability in adults with cerebellar high-grade gliomas.探讨成人小脑高级别胶质瘤的独特临床特征并构建生存概率列线图模型。
BMC Cancer. 2024 Jul 13;24(1):836. doi: 10.1186/s12885-024-12580-4.
2
Variable screening and model construction for prognosis of elderly patients with lower-grade gliomas based on LASSO-Cox regression: a population-based cohort study.基于 LASSO-Cox 回归的老年低级别胶质瘤患者预后的变量筛选和模型构建:一项基于人群的队列研究。
Front Immunol. 2024 Sep 11;15:1447879. doi: 10.3389/fimmu.2024.1447879. eCollection 2024.
3
Nomograms for predicting the overall survival of patients with cerebellar glioma: an analysis of the surveillance epidemiology and end results (SEER) database.预测小脑胶质瘤患者总生存期的列线图:监测、流行病学和最终结果(SEER)数据库分析。
Sci Rep. 2021 Sep 29;11(1):19348. doi: 10.1038/s41598-021-98960-3.
4
BTK Expression Level Prediction and the High-Grade Glioma Prognosis Using Radiomic Machine Learning Models.基于放射组学机器学习模型的 BTK 表达水平预测与高级别胶质瘤预后
J Imaging Inform Med. 2024 Aug;37(4):1359-1374. doi: 10.1007/s10278-024-01026-9. Epub 2024 Feb 21.
5
Prognostic Nomograms for Primary High-Grade Glioma Patients in Adult: A Retrospective Study Based on the SEER Database.成人原发性高级别胶质瘤患者预后列线图:基于 SEER 数据库的回顾性研究。
Biomed Res Int. 2020 Jul 23;2020:1346340. doi: 10.1155/2020/1346340. eCollection 2020.
6
[Development and Evaluation of Prognostic Nomogram Model for Adult Ventricle Glioma Patients].[成人脑室胶质瘤患者预后列线图模型的建立与评估]
Sichuan Da Xue Xue Bao Yi Xue Ban. 2022 Jul;53(4):588-596. doi: 10.12182/20220760203.
7
Can a Nomogram Help to Predict the Overall and Cancer-specific Survival of Patients With Chondrosarcoma?列线图能否预测软骨肉瘤患者的总生存和癌症特异性生存?
Clin Orthop Relat Res. 2018 May;476(5):987-996. doi: 10.1007/s11999.0000000000000152.
8
Prognostic factors and clinical nomogram predicting survival in high-grade glioma.高级别胶质瘤患者生存预后的影响因素和临床列线图预测模型。
J Cancer Res Ther. 2021 Jul-Sep;17(4):1052-1058. doi: 10.4103/jcrt.JCRT_233_19.
9
Epidemiological trends, relative survival, and prognosis risk factors of WHO Grade III gliomas: A population-based study.WHO 分级 III 级胶质瘤的流行病学趋势、相对生存率和预后危险因素:一项基于人群的研究。
Cancer Med. 2019 Jun;8(6):3286-3295. doi: 10.1002/cam4.2164. Epub 2019 Apr 24.
10
Development and validation of a nomogram for predicting cancer-specific survival in small-bowel adenocarcinoma patients using the SEER database.基于 SEER 数据库的列线图模型构建与验证:用于预测小肠腺癌患者癌症特异性生存的研究。
World J Surg Oncol. 2024 Jun 7;22(1):151. doi: 10.1186/s12957-024-03438-x.

本文引用的文献

1
Modifiable risk factors for glioblastoma: a systematic review and meta-analysis.可改变的胶质母细胞瘤风险因素:系统回顾和荟萃分析。
Neurosurg Rev. 2023 Jun 20;46(1):143. doi: 10.1007/s10143-023-02051-y.
2
Cerebellar High-Grade Glioma: A Translationally Oriented Review of the Literature.小脑高级别胶质瘤:文献的转化导向性综述
Cancers (Basel). 2022 Dec 28;15(1):174. doi: 10.3390/cancers15010174.
3
Nomograms for predicting the overall survival of patients with cerebellar glioma: an analysis of the surveillance epidemiology and end results (SEER) database.
预测小脑胶质瘤患者总生存期的列线图:监测、流行病学和最终结果(SEER)数据库分析。
Sci Rep. 2021 Sep 29;11(1):19348. doi: 10.1038/s41598-021-98960-3.
4
Treatment patterns and outcomes for cerebellar glioblastoma in the concomitant chemoradiation era: A National Cancer database study.同期放化疗时代小脑胶质母细胞瘤的治疗模式和结局:一项国家癌症数据库研究。
J Clin Neurosci. 2020 Dec;82(Pt A):122-127. doi: 10.1016/j.jocn.2020.10.049. Epub 2020 Nov 6.
5
The effect of race on the prognosis of the glioblastoma patient: a brief review.种族对胶质母细胞瘤患者预后的影响:简要综述
Neurol Res. 2019 Nov;41(11):967-971. doi: 10.1080/01616412.2019.1638018. Epub 2019 Jul 4.
6
Association of MGMT Promoter Methylation Status With Survival Outcomes in Patients With High-Risk Glioma Treated With Radiotherapy and Temozolomide: An Analysis From the NRG Oncology/RTOG 0424 Trial.MGMT 启动子甲基化状态与接受放疗和替莫唑胺治疗的高危胶质瘤患者生存结局的相关性:来自 NRG 肿瘤学/RTOG 0424 试验的分析。
JAMA Oncol. 2018 Oct 1;4(10):1405-1409. doi: 10.1001/jamaoncol.2018.1977.
7
Cerebellar high-grade gliomas do not present the same molecular alterations as supratentorial high-grade gliomas and may show histone H3 gene mutations.小脑高级别胶质瘤不存在与幕上高级别胶质瘤相同的分子改变,且可能显示组蛋白H3基因突变。
Clin Neuropathol. 2018 Sep/Oct;37(5):209-216. doi: 10.5414/NP301104.
8
Current Challenges and Opportunities in Treating Glioblastoma.治疗脑胶质母细胞瘤的当前挑战与机遇。
Pharmacol Rev. 2018 Jul;70(3):412-445. doi: 10.1124/pr.117.014944.
9
Characteristics of cerebellar glioblastomas in adults.成人小脑胶质母细胞瘤的特征。
J Neurooncol. 2018 Feb;136(3):555-563. doi: 10.1007/s11060-017-2682-7. Epub 2017 Dec 1.
10
Prognostication of Survival Outcomes in Patients Diagnosed with Glioblastoma.预测诊断为胶质母细胞瘤患者的生存结局。
World Neurosurg. 2018 Jan;109:e67-e74. doi: 10.1016/j.wneu.2017.09.104. Epub 2017 Sep 23.